"So let me say two things immediately about the now-published results for lecanemab, the latest attempt at anti-amyloid antibody therapy for Alzheimer’s. I think that both of these are true: the numbers are the best that I have yet seen for such an antibody, and at the same time I doubt if the drug will actually make a difference in the treatment of #Alzheimer’s."
- Derek Lowe

https://www.science.org/content/blog-post/lecanemab-and-alzheimer-s-more-data?s=09